Our study shows that in pancreatic cancer, CD133+ cells have a high expression of GAS5 (Fig. 3), which is regulated by the self-renewal transcription factor Sox2 (Fig. 5). This evidence concerns the gene GAS5 and familial pancreatic carcinoma.